Leslie D. Funtleyder Applied Therapeutics Inc. (APLT) insider trading activity

Leslie D. Funtleyder is Chief Financial Officer of Applied Therapeutics Inc.. Currently has a direct ownership of 1.34 Million shares of APLT, which is worth approximately $294,900. The most recent transaction as insider was on Jan 01, 2026, when has been sold 150,000 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 1.34M

12.6% 3M change

213.26% 12M change

Total Value Held $294,900

Leslie D. Funtleyder Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Jan 01 2026	BUY Grant, award, or other acquisition	-	150,000 Added 10.06%	1,340,459 Common Stock
Oct 01 2025	BUY Grant, award, or other acquisition	-	150,000 Added 11.19%	1,190,459 Common Stock
Jul 01 2025	BUY Grant, award, or other acquisition	-	150,000 Added 13.8%	937,121 Common Stock
Jun 09 2025	BUY Grant, award, or other acquisition	-	150,000 Added 16.01%	787,121 Common Stock
Mar 24 2025	BUY Grant, award, or other acquisition	-	350,000 Added 32.1%	740,459 Common Stock
Mar 04 2025	SELL Open market or private sale	$6,380 $0.44 p/Share	14,502 Reduced 3.58%	390,459 Common Stock
Feb 06 2025	SELL Open market or private sale	$13,999 $0.61 p/Share	22,950 Reduced 5.36%	404,961 Common Stock

Dec 19 2024	BUY Grant, award, or other acquisition	-	150,000 Added 25.96%	427,911 Common Stock
Aug 22 2024	SELL Open market or private sale	$78,879 $5.83 p/Share	13,530 Reduced 4.64%	277,911 Common Stock
Jun 06 2024	SELL Open market or private sale	$73,353 $4.32 p/Share	16,980 Reduced 5.51%	291,441 Common Stock
Mar 14 2024	SELL Open market or private sale	$154,838 $5.39 p/Share	28,727 Reduced 8.52%	308,421 Common Stock
Nov 20 2023	BUY Grant, award, or other acquisition	-	300,000 Added 47.08%	337,148 Common Stock
Jun 06 2023	BUY Grant, award, or other acquisition	-	20,000 Added 35.0%	37,148 Common Stock
Oct 02 2020	SELL Open market or private sale	$119,938 $20.07 p/Share	5,976 Reduced 25.84%	17,148 Common Stock
Oct 01 2020	SELL Open market or private sale	$489,849 $20.39 p/Share	24,024 Reduced 50.95%	23,124 Common Stock
Oct 01 2020	SELL Exercise of conversion of derivative security	$141,000 $4.7 p/Share	30,000 Reduced 38.89%	47,148 Common Stock

Also insider at

RVPH

REVIVA PHARMACEUTICALS HOLDINGS, INC. Healthcare

Director

LDF